Study of T3 for the Treatment of Fibromyalgia
NCT00903877
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Fibromyalgia
Interventions
DRUG:
T3
Sponsor
Stanford University